Literature DB >> 2935149

Changes in the content of atrial natriuretic factor with the progression of hypertension in spontaneously hypertensive rats.

T Imada, R Takayanagi, T Inagami.   

Abstract

In order to assess possible roles of atrial natriuretic factor (ANF) in spontaneously hypertensive rats (SHR), we examined the content of immunoreactive-ANF in plasma, the atria, hypothalamus and pons of SHR and Wister Kyoto (WKY) rats by radioimmunoassay at different stages of age. With the progression of hypertension, plasma concentration of ANF increased whereas it decreased in the atria in SHR. This suggests ANF is secreted in response to hypertension. On the other hand, at hypothalamus and pons, ANF content was significantly higher in SHR than in WKY rats. This finding suggests possible involvement of ANF in the central regulation of blood pressure.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2935149     DOI: 10.1016/0006-291x(85)90969-6

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  16 in total

1.  Is atriopeptin a physiological or pathophysiological substance? Studies in the autoimmune rat.

Authors:  J E Greenwald; M Sakata; M L Michener; S D Sides; P Needleman
Journal:  J Clin Invest       Date:  1988-04       Impact factor: 14.808

2.  Synthesis of atrial natriuretic polypeptide in human failing hearts. Evidence for altered processing of atrial natriuretic polypeptide precursor and augmented synthesis of beta-human ANP.

Authors:  A Sugawara; K Nakao; N Morii; T Yamada; H Itoh; S Shiono; Y Saito; M Mukoyama; H Arai; K Nishimura
Journal:  J Clin Invest       Date:  1988-06       Impact factor: 14.808

3.  Developmental changes in the rat atriopeptin hormonal system.

Authors:  Y F Wei; C P Rodi; M L Day; R C Wiegand; L D Needleman; B R Cole; P Needleman
Journal:  J Clin Invest       Date:  1987-05       Impact factor: 14.808

4.  Intradermal administration of atrial natriuretic peptide has no effect on sweating and cutaneous vasodilator responses in young male adults.

Authors:  Naoto Fujii; Brendan D McNeely; Takeshi Nishiyasu; Glen P Kenny
Journal:  Temperature (Austin)       Date:  2017-10-09

5.  Atrial natriuretic polypeptide inhibits hypertrophy of vascular smooth muscle cells.

Authors:  H Itoh; R E Pratt; V J Dzau
Journal:  J Clin Invest       Date:  1990-11       Impact factor: 14.808

Review 6.  [Atrial natriuretic peptide and its significance for arterial hypertension].

Authors:  G Wambach; M Stimpel; G Bönner
Journal:  Klin Wochenschr       Date:  1989-11-03

Review 7.  Atrial natriuretic peptide in the central nervous system of the rat.

Authors:  G Skofitsch; D M Jacobowitz
Journal:  Cell Mol Neurobiol       Date:  1988-12       Impact factor: 5.046

Review 8.  Discovery of atrial natriuretic factor in the brain: its characterization and cardiovascular implication.

Authors:  T Inagami; I Tanaka; J C McKenzie; M Nakamaru; R Takayanagi; T Imada; R Pochet; A Resibois; M Naruse; K Naruse
Journal:  Cell Mol Neurobiol       Date:  1989-03       Impact factor: 5.046

9.  Atrial natriuretic peptide and angiotensin II binding sites in cerebral capillaries of spontaneously hypertensive rats.

Authors:  M Ibaragi; M Niwa
Journal:  Cell Mol Neurobiol       Date:  1989-06       Impact factor: 5.046

10.  Increased cyclic guanosine monophosphate production and overexpression of atrial natriuretic peptide A-receptor mRNA in spontaneously hypertensive rats.

Authors:  J Tremblay; C Huot; R C Willenbrock; F Bayard; F Gossard; N Fujio; C Koch; O Kuchel; W Debinski; P Hamet
Journal:  J Clin Invest       Date:  1993-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.